$8.09
4.76% yesterday
Nasdaq, Jun 26, 10:00 pm CET
ISIN
US71716E1055
Symbol
PHAR

Pharming Group N.V. - ADR Share price

$8.09
-1.22 13.13% 1M
-3.91 32.60% 6M
-3.34 29.24% YTD
-2.90 26.40% 1Y
-3.40 29.58% 3Y
-8.61 51.57% 5Y
-8.61 51.57% 10Y
Nasdaq, Closing price Wed, Jun 26 2024
ISIN
US71716E1055
Symbol
PHAR
Sector
Industry

Key figures

Market capitalization $544.65m
Enterprise Value $509.89m
PER (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 1.97
P/S ratio (TTM) P/S ratio 2.11
P/B ratio (TTM) P/B ratio 2.64
Sales growth (TTM) Sales growth 28.23%
Turnover (TTM) Turnover $258.47m
EBIT (operating result TTM) EBIT $-31.03m
Free cash flow (TTM) Free cash flow $-7.13m
Cash position $201.97m
EPS (TTM) EPS $-0.15
P/E ratio expected 80.88
P/S ratio expected 1.89
EV/Sales expected 1.77
Show more

Is Pharming Group N.V. - ADR a top scorer stock according to the dividend, high growth investing or Leverman strategy?

As a free StocksGuide basic user, you can view the scores for all 6,947 shares worldwide.

Pharming Group N.V. - ADR Share analysis

Unlock scores for free

Analyst opinions

5 Analysts have issued a Pharming Group N.V. - ADR forecast:

5x Buy
100%

Analyst opinions

5 Analysts have issued a Pharming Group N.V. - ADR forecast:

Buy
100%

Financial data from Pharming Group N.V. - ADR

Profit and loss account P&L | Balance sheet | Cash flow


Quarter TTM Annually
Mar '24
+/-
%
258 258
28% 28%
100%
- Direct costs 37 37
56% 56%
14%
221 221
25% 25%
86%
- Selling and administrative expenses 161 161
30% 30%
62%
- Research and development costs 72 72
35% 35%
28%
-11 -11
1,810% 1,810%
-4%
- Depreciation and amortization 20 20
47% 47%
8%
EBIT (operating result) EBIT -31 -31
145% 145%
-12%
Net profit -10 -10
347% 347%
-4%

Figures in millions USD.

Don't miss a thing! We will send you all news about the Pharming Group N.V. - ADR share directly to your mailbox free of charge.

If you wish, you can receive an e-mail every morning in time for breakfast containing all the stock news relevant to you.

Pharming Group N.V. - ADR Share News

Neutral
GlobeNewsWire
28 days ago
L eiden , the Netherlands, May 30, 2024 : Pharming Group N.V. (“Pharming” or “the Company”) (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) announces today an update on the ongoing review of its Marketing Authorisation Application (MAA) for leniolisib for the treatment of adult and pediatric patients 12 years of age and older with activated phosphoinositide 3-kinase delta syndrome (APDS) by the Commit...
Neutral
GlobeNewsWire
about one month ago
Leiden, the Netherlands, May 21, 2024: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext: PHARM/Nasdaq: PHAR) announces that at its Annual General Meeting of Shareholders (AGM) held today, all proposals were approved.The shareholders approved the proposals to reappoint Ms. Barbara Yanni (agenda item 4.a) and Mr. Mark Pykett (agenda item 4.b), upon binding recommendation of the Board o...
Neutral
Seeking Alpha
about 2 months ago
Pharming Group N.V. (NASDAQ:PHAR ) Q1 2024 Earnings Conference Call May 8, 2024 7:30 AM ET Company Participants Sijmen de Vries - Executive Director and Chief Executive Officer Stephen Toor - Chief Commercial Officer Anurag Relan - Chief Medical Officer Jeroen Wakkerman - Chief Financial Officer Conference Call Participants Christian Glennie - Stifel Sushila Hernandez - Van Lanschot Kempen Joe ...
More Pharming Group N.V. - ADR News

Company profile

Pharming Group NV is a holding company, which engages in the development of pharmaceutical products for the treatment of rare diseases and unmet medical needs. The company offers RUCONEST which is a recombinant human C1-esterase inhibitor for the treatment of acute hereditary angioedema. It operates through the following geographical segments: the United States, Europe, and Rest of the World. The company was founded on November 11, 1988 and is headquartered in Leiden, the Netherlands.

Head office Netherlands
CEO Sijmen Vries
Founded 1988
Website www.pharming.com

Register for free

StocksGuide is the tool for easily finding, analyzing and monitoring shares. Learn from successful investors and make well-founded investment decisions. We make you a self-determined investor.

The Apple share at a glance with charts, current key figures, news and share analyses.
The best dividend stocks in the dividend top scorer list.
Stock analyses of the best stocks worldwide.
Build wealth now